Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 65Neoplasm Metastasis 14Brain Neoplasms 10Neoplasms 9Endometrial Neoplasms 8Prostatic Neoplasms 7Glioblastoma 7Ovarian Neoplasms 6Triple Negative Breast Neoplasms 5Glioma 5Sarcoma 4Recurrence 3Neoplasms by Site 3Meningioma 3Liposarcoma 3Carcinoma, Non-Small-Cell Lung 3Breast Diseases 3Unilateral Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma, Ewing 2Osteosarcoma 2Head and Neck Neoplasms 2Fallopian Tube Neoplasms 2Ependymoma 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Advanced Breast Cancer 2Venous Thromboembolism 1Uterine Cervical Neoplasms 1

Interventions

Specimen Handling 9Tamoxifen 8Radiotherapy 6exemestane 3Radiation Dose Hypofractionation 3Radiation 3Letrozole 3Anastrozole 3Surveys and Questionnaires 2Sentinel Lymph Node Biopsy 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Conformal 2Patient Navigation 2Observation 2Metformin 2Mastectomy 2Magnetic Resonance Spectroscopy 2Genetic Testing 2Biopsy 2trastuzumab biosimilar HLX02 1ruxolitinib 1poly ICLC 1palbociclib 1fezolinetant 1elacestrant 1afimoxifene 1abemaciclib 1Trastuzumab 1Testosterone 1Tablets 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Intraductal, Noninfiltrating × abemaciclib × 1 year × Clear all
NCT03979508 2025-11-12

Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer

Mayo Clinic

Phase 2 Terminated
26 enrolled
Breast

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating, Fibrocystic Breast Disease, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡